Submission of Intimation of closure of trading window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astal Laboratories Limited has informed the BSE that the trading window for dealing in its securities will remain closed for all directors, officers, designated persons, and their immediate relatives from 1st April 2026 until 48 hours after the declaration of the audited financial results for the quarter ended 31st March 2026. This is a standard compliance filing under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The date of the board meeting to consider and approve the Q4 (FY26) audited financial results will be communicated separately. The intimation was signed by Mahendra Kumar, Company Secretary & Compliance Officer.
This is a routine regulatory disclosure and does not directly impact the stock price. However, it signals that the company's Q4 FY26 audited results are forthcoming, and investors should watch for the board meeting announcement in the coming weeks.